Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |